NWEH publications 2006-2015
2015
Savas LA, Grady K, Cotterill S, Summers L, Boaden R, Gibson JM (2015) Prioritising prevention:
implementation of IGT Care Call, a telephone based service for people at risk of developing type 2
diabetes. Primary care diabetes 9:3-8
New JP, Ajjan R, Pfeiffer AF, Freckmann G. (2015) Continuous glucose monitoring in people with
diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet
Med. May: 609-11
Nadif R, Dilworth MR, Sibley CP, Baker PN, Davidge ST, Gibson JM, Aplin JD, Westwood M (2015) The
maternal environment programs postnatal weight gain and glucose tolerance of male offspring, but
placental and fetal growth are determined by fetal genotype in the Leprdb/+ model of gestational
diabetes. Endocrinology 156:360-366
Khan A, Gibson JM, Carlson G, Rooyackers O, New J, Soop M (2015) Protein kinetics in human
endotoxaemia and their temporal relation to metabolic, endocrine and proinflammatory cytokine
responses. British Journal of Surgery 102:767-775
Elkhenini HF, New JP, Syed AA. (2014) Five-year outcome of bariatric surgery in a patient with
melanocortin-4 receptor mutation. Clin Obes. Apr; 4: 121-4.
Forbes K, Shah VK, Siddals K, Gibson JM, Aplin JD, Westwood M (2015) Statins inhibit insulin-like
growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor
glycosylation. Mol Hum Reprod 21:105-114
Elkhenini HF, Davis KJ, Stein ND, New JP, Delderfield MR, Gibson JM, Vestbo J, Woodcock A, Bakerly
ND (2015) Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study
feasibility. BMC medical informatics and decision making 15:8
2014
New JP, Bakerly ND, Leather D, Woodcock A. (2014) Obtaining real-world evidence: the Salford Lung
Study. Thorax. Dec; 69(12): 1152-4
Yadav R, France M, Aghamohammadzadeh R, Liu Y, Hama S, Kwok S, Schofield J, Turkington P, Syed
AA, Malik R, Pemberton P, Greenstein A, Durrington P, Ammori B, Gibson JM, Jeziorska M, Soran H
(2014) Impairment of High Density Lipoprotein Resistance to Lipid Peroxidation and Adipose Tissue
Inflammation in Obesity Complicated by Obstructive Sleep Apnea. J Clin Endocrinol
Metab:jc20133939
Behbehani F, Ammori BJ, New JP, Summers LK, Soran H, Syed AA. (2014) Metabolic outcomes 2
years following gastric bypass surgery in people with type 2 diabetes: an observational cohort study.
QJM. Sep; 107(9):721-6.
Solomon AL, Siddals KW, Baker PN, Gibson JM, Aplin JD, Westwood M (2014) Placental alkaline
phosphatase de-phosphorylates insulin-like growth factor (IGF)-binding protein-1. Placenta 35:520522
Elkhenini H, New JP, Summers LK, Syed AA. (2014) Liraglutide therapy in obese people with type 2
diabetes - experience of a weight management centre. Eur J Intern Med. Mar;25(3):e38-9
Narayanan RP, Fu B, Oliver RL, Siddals KW, Donn R, Hudson JE, White A, Laing I, Ollier WE, Heald AH,
Gibson JM (2014) Insulin-like growth factor-II and insulin-like growth factor binding protein-2
prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes. Annals of clinical
biochemistry 51:468-475
Nadif R, Dilworth MR, Sibley CP, Baker PN, Davidge ST, Gibson JM, Aplin JD, Westwood M (2014) The
Maternal Environment Programs Postnatal Weight Gain and Glucose Tolerance of Male Offspring,
but Placental and Fetal Growth Are Determined by Fetal Genotype in the Leprdb/+ Model of
Gestational Diabetes. Endocrinology 156:360-366
Kalankesh LR, New JP, Baker PG, Brass A. (2014) The languages of health in general practice
electronic patient records: a Zipf's law analysis. J Biomed Semantics. Jan 10;5(1):2
2013
Narayanan RP, Gittins M, Siddals KW, Oliver RL, Hudson JE, White A, Durrington P, Davies RR, Rutter
MK, Gibson JM (2013) Atorvastatin administration is associated with dose-related changes in IGF
bioavailability. European Journal of Endocrinology 168:543-548
Narayanan RP, Fu B, Oliver RL, Siddals KW, Donn R, Hudson JE, White A, Laing I, Ollier WE, Heald AH,
Gibson JM (2013) Insulin-like growth factor-II and insulin-like growth factor binding protein-2
prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes. Annals of Clinical
Biochemistry: An international journal of biochemistry and laboratory medicine:0004563213499145
Alatishe A, Ammori BJ, New JP, Syed AA. (2013) Bariatric surgery in women of childbearing age. QJM.
Aug;106(8):717-20
Narayanan RP, Fu B, Heald AH, Siddals KW, Oliver RL, Hudson JE, Payton A, Anderson SG, White A,
Ollier WE, Gibson JM (2013) IGFBP2 is a biomarker for predicting longitudinal deterioration in renal
function in type 2 diabetes. Endocrine Connections 2:X1
Narayanan R, Siddals K, Heald A, Gibson JM (2013) Interactions of the IGF System with Diabetes and
its Vascular Complications. Experimental and Clinical Endocrinology & Diabetes 121:255-261
Narayanan R, Fu B, Payton A, Hudson J, Oliver R, Anderson S, Siddals K, White A, Ollier W, Heald A,
Gibson JM (2013) IGF2 Gene Polymorphisms and IGF-II Concentration are Determinants of
Longitudinal Weight Trends in Type 2 Diabetes. Experimental and clinical endocrinology & diabetes:
official journal, German Society of Endocrinology [and] German Diabetes Association 121:361-367
Betzlbacher A-F, Grady K, Savas L, Cotterill S, Boaden R, Summers L, Gibson JM (2013) Behaviour
change among people with impaired glucose tolerance: Comparison of telephone-based and face-toface advice. Journal of Health Services Research & Policy 18:2-6
2012
Tierney S, Mamas M, Woods S, Rutter MK, Gibson JM, Neyses L, Deaton C (2012) What strategies
are effective for exercise adherence in heart failure? A systematic review of controlled studies. Heart
failure reviews 17:107-115
Narayanan RP, Fu B, Heald AH, Siddals KW, Oliver RL, Hudson JE, Payton A, Anderson SG, White A,
Ollier WE (2012) IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in
type 2 diabetes. Endocrine Connections 1:95-102
Narayanan R, Mason J, Taylor J, Long A, Gambling T, New J, Gibson JM, Young R (2012) Telemedicine
to improve glycaemic control: 3‐year results from the Pro‐Active Call Centre Treatment Support
(PACCTS) trial. Diabetic Medicine 29:284-285
Narayanan R, Anderson S, Fu B, Payton A, White A, Ollier W, Gibson JM, Heald A (2012) An IGF2
receptor gene polymorphism modulates blood pressure trends over time in type 2 diabetes. Artery
Research 6:159
Ainsworth J, Cunningham J, Buchan I. (2012). eLab: Bringing Together People, Data and Methods to
Enhance Knowledge Discovery in Healthcare Settings. Studies in health technology and informatics,
175, 39-48. eScholarID:187786
Ainsworth, J. & Buchan, I (2012). COCPIT: A Tool for Integrated Care Pathway Variance
Analysis. Studies in health technology and informatics, 180, 995-9. eScholarID:177233
Ainsworth, J., Cunningham, J. & Buchan, I (2012). eLab: bringing together people, data and methods
to enhance knowledge discovery in healthcare settings. Studies in health technology and
informatics, 175, 39-48. eScholarID:177231
Alistair Sutcliffe, Oscar de Bruijn, Sarah Thew, Iain Buchan, Paul Jarvis, John McNaught and Rob
Procter. (2012). Developing visualization-based decision Support Tools for Epidemiology. SAGE
Journals, eScholarID:162023 | DOI:10.1177/1473871612445832
2011
Tierney S, Mamas M, Skelton D, Woods S, Rutter MK, Gibson JM, Neyses L, Deaton C (2011) What
can we learn from patients with heart failure about exercise adherence? A systematic review of
qualitative papers. Health Psychology 30:401
Bechhofer S, Buchan I, De Roure D, Missier P, Ainsworth J, Bhagat J, Couch P, Cruickshank D,
Delderfield M, Dunlop I, Gamble M, Michaelides D, Owen S, Newman D, Sufi D, Goble C. (2011). Why
linked data is not enough for scientists. Future Generation Computer Systems, eScholarID:133602 |
DOI:10.1016/j.future.2011.08.004
Tierney S, Elwers H, Sange C, Mamas M, Rutter MK, Gibson JM, Neyses L, Deaton C (2011) What
influences physical activity in people with heart failure? A qualitative study. International journal of
nursing studies 48:1234-1243
Thew, S., Leeming, G., Ainsworth, J., Gibson, M. & Buchan, I (2011). FARSITE: evaluation of an
automated trial feasibility assessment and recruitment tool. Trials, 12 Suppl 1(Suppl 1), A113.
eScholarID:177229 | DOI:10.1186/1745-6215-12-S1-A113
Siddals KW, Allen J, Sinha S, Canfield AE, Kalra PA, Gibson JM (2011) Apposite insulin-like growth
factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle
phenotype in the presence of factors promoting osteogenic differentiation and mineralization.
Journal of Biological Chemistry 286:16623-16630
Matthew Sperrin, Sarah Thew, James Weatherall, William Dixon, and Iain Buchan (2011).
Quantifying the longitudinal value of healthcare record collections for pharmacoepidemiology. AMIA
Annu Symp Proc. 22nd Oct 2011; 2011: 1318–1325
Narayanan RP, Mason JM, Taylor J, Long AF, Gambling T, New JP, Gibson JM, Young RJ. (2011)
Telemedicine to improve glycaemic control: 3-year results from the Pro-Active Call Centre Treatment
Support (PACCTS) trial. Diabetic Medicine. (In Press: doi: 10.1111/j.1464-5491.2011.03352)
Rutter M, Prais H, Charlton‐Menys V, Gittins M, Roberts C, Davies R, Moorhouse A, Jinadev P, France
M, Wiles P, Gibson JM, Durrington PN (2011) Protection Against Nephropathy in Diabetes with
Atorvastatin (PANDA): a randomized double‐blind placebo‐controlled trial of high‐vs. low‐dose
atorvastatin1. Diabetic Medicine 28:100-108
Demssie YN, Jawaheer J, Farook S, New JP, Syed AA. (2011) Metabolic Outcomes 1 Year after Gastric
Bypass Surgery in Obese People with Type 2 Diabetes. Med Princ Pract.
J. New, M. Delderfield, N. Stein, S.Austin, J. Vestbo, A. Woodcock. (2011) Assessing the burden of
asthma and COPD in Salford UK: Retrospective analysis using a whole population electronic medical
record. ERC Annual Conference September
Hoefield RA, Kalra PA, Baker PG, Sousa I, Diggle PJ, Gibson MJ, O’Donoghue DJ, Middleton RJ, New
JP (2011) The use of eGFR and ACR to predict decline in renal function in people with diabetes.
Nephrology Dialysis Transplantation 26:887-892
Deaton C, Mamas MA, Rutter MK, Gibson M, Bowell S, Byrne R, Coezy K, Gow J, Williams S (2011)
Glucose and insulin abnormalities in patients with heart failure. European Journal of Cardiovascular
Nursing 10:75-87
RJ Stack, C Bundy, RA Elliott, JP New, M Gibson, PR Noyce (2011) Patient perceptions of treatment
and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes, Metabolic
Syndrome and Obesity: Targets and Therapy; 4; 127-135
Sutcliffe, A., Thew, S., Jarvis, P., Experience with user-centred requirements engineering,
Requirements Eng. (2011) 16:267-280, DOI 10.1007/s00766-011-0118-z
Buchan IE. (2011). Informatics in Healthcare Systems. In Walshe K (Ed.), Healthcare Management.
eScholarID:107716
Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ. (2011) Predictors of remission of type
2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis; 6: 691-6
2010
Stack RJ, Bundy C, Elliott RA, New JP, Gibson JM, Noyce PR (2010) Patient perceptions of treatment
and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes, metabolic
syndrome and obesity: targets and therapy 4:127-135
Goodacre J, Gibson M, Wilson K, Alfirevic Z, Farrar M, Darbyshire J (2010) Improved UK clinical trial
capacity through the North West Exemplar Programme. Nature medicine 16:516-516
Buchan I, Ainsworth J, Thew S, Leeming G. (2010). NHS e-Labs: Engineering Digital Health Economies.
Presented at Digital Futures. Nottingham. eScholarID:116061
Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, Hegarty J, New J, O'Donoghue DJ,
Middleton RJ, Kalra PA. (2010) Serum Phosphate and Mortality in Patients with Chronic Kidney
Disease. Clin J Am Soc Nephrol; 5: 2251-7
R J Stack, C E Bundy, R A Elliott, JP New, M Gibson, PR Noyce (2010) Intentional and unintentional
non-adherence in community dwelling people with type 2 diabetes: the effect of varying numbers of
medicines. Journal diabetes vascular complications 2010: 10: 148-152.
Mamas MA, Deaton C, Rutter MK, Yuille M, Williams SG, Ray SG, New J, Gibson JM, Neyses L (2010)
Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and
undertreated? Journal of cardiac failure 16:761-768
Buchan I. (2010). NHS e-Lab & NorthWest e-Health: Harnessing health record data for patients and
communities. Presented at EHTEL10, AER and EUREGHA Joint Symposium. Brussels: European
Commission. eScholarID:116066
Buchan I. (2010). NHS e-Lab for Efficient Trials: Feasibility analysis and trials-management making
best use of care records. Presented at NOCRI workshop. Oxford. eScholarID:116069
Hoyle A, Crowther P, Delderfield M, Kitching L, Smith G, Buchan I. (2010). Sharing paths of
exploration to support collaborative reasoning in genomic data analysis. Presented at Medinfo 2010:
13th World Congress on Medical Informatics. Capetown: IOS Press. eScholarID:116045
Thew S, Jarvis P, Ainsworth J, Buchan I. (2010). Obesity atlas and methodbox: towards an open
framework for sharing public health intelligence workflows. Presented at Medinfo 2010. Capetown.
eScholarID:116041
Hoyle D, Delderfield M, Kitching L, Smith G, Buchan I. (2010). Shared Genomics: Developing an
accessible integrated analysys platform for Genome-Wide Association Studies. AMIA Summits Transl
Sci Proc, 2010(Mar 1), 18-22. eScholarID:133523
Sutcliffe A, Thew S, De Bruijn O, Buchan I, Jarvis P, McNaught J, Procter R. (2010). User engagement
by user-centred design in e-Health. Philos Transact A Math Phys Eng Sci, 368(1926), 4209-4224.
eScholarID:116055 | DOI:10.1098/rsta.2010.0141
Thew SL, Sutcliffe A, de Bruijn O, McNaught J, Procter R, Jarvis P, Buchan I. (2010). Supporting
Creativity and Appreciation of Uncertainty in Exploring Geo-coded Public Health Data. Methods of
Information in Medicine, 49(5), eScholarID:116050
2009
Ainsworth J, Buchan I. (2009). e-Labs and Work Objects: Towards Digital Health Economies.
Presented at Europecomm 2009. London: Springer. eScholarID:71577
Ainsworth J, Buchan I. (2009). FARSITE for Healthcare e-Labs: Clinical Study Feasibility and Consent
Architecture. Presented at Healthgrid 2009. Berlin. eScholarID:71551
Buchan I, Sufi S., Thew S., Dunlop I., Hiroeh U., Canoy D., Moulton G., Ainsworth J., Dale A.,
Bechhofer S., Goble C., Obesity e-Lab: Connecting Social Science via Research Objects, in 5th
International Conference on e-Social Science (2009), eScholarID: 99448
Ainsworth J, Goble C, Rector A, O'Brien S, Buchan I. (2009). Public Health e-Labs: An ethical model
and architecture for distributed epidemiology using healthcare records. Presented at Public Health
Information Network. Altanta. eScholarID:71454
I Buchan, C Goble, A Dale, S Sufi, S Thew, I Dunlop, D Canoy, U Hiroeh, G Moulton, J Ainsworth.
(2009). MethodBox: Survey Alchemy. Presented at UK e-Science All Hands. Oxford. eScholarID:85581
I Buchan, John Ainsworth, David Hoyle, Mark Delderfield, Gareth Smith, Lee Kitching, John New,
Carole Goble, John Winn, Chris Bishop. (2009). Healthcare e-Labs: Opening and Integrating Models
of Health. Presented at Microsoft eScience 2009. Pittsburgh: Microsoft Research. eScholarID:71492
S Thew, A Sutcliffe, J McNaught, P Jarvis, R Procter, O de Bruijn, C Goble, A Dale, S Sufi, S Thew, I
Dunlop, D Canoy, U Hiroeh, G Moulton, J Ainsworth, I Buchan. (2009). Supportive creative thinking in
Public Health Research – the ADVISES and Obesity e-Lab projects. Presented at International e-Social
Science Conference. Frankfurt. eScholarID:85583
Ainsworth J, Buchan I. (2009) Preserving consent-for-consent with feasibility-assessment and
recruitment in clinical studies: FARSITE architecture. Studies in Health Information Technology;
147:137-148.
2008
New J, Aung T, Baker P, Yongsheng G, Pylypczuk R, Houghton J, Rudenski A, New R, Hegarty J, Gibson
JM (2008) The high prevalence of unrecognized anaemia in patients with diabetes and chronic
kidney disease: a population‐based study. Diabetic Medicine 25:564-569
Hoefield RA, Baker PG, Kalra PA, Buchan AE, Gibson JM, Middleton RJ, New JP (2008)
Microalbuminuria and reduced glomerular filtration rate are independent factors for mortality in
people with diabetes mellitus. Diabetes, 2008, pp A215-A215
Forbes K, Hurst LM, Gibson JM, Aplin JD, Westwood M (2008) Statins are detrimental to human
placental development and function; use of statins during early pregnancy is inadvisable. Journal of
cellular and molecular medicine 12:2295-2296
JP New, T Aung, P Baker, Y Gao, R Pylypczuk, J Houghton, A Rudenski, RP, J Hegarty, JM Gibson, DJ
O'Donoghue, IE Buchan (2008) Methodology problems in using eGFR to investigate the prevalence of
renal anaemia. Authors reply Diabetic Medicine; 25: 1127-1127
2007
Ainsworth J, Baker P, New J, Gibson M, Pioli D, Buchan I. (2007). Public Health e-Labs: A federated
model for e-Epidemiology. Presented at Public Health Informatics 2007. Seattle. eScholarID:71433
Salonen JT, Uimari P, Aalto J-M, Pirskanen M, Kaikkonen J, Todorova B, Hyppönen J, Korhonen V-P,
Asikainen J, Devine C, Gibson JM et al (2007) Type 2 diabetes whole-genome association study in
four populations: the DiaGen consortium. The American Journal of Human Genetics 81:338-345
JP New, DJ O’Donoghue, RJ Middleton, A Rudenski, I Dasgupta, R W Bilous, SM Marshall (2007) Time
to move from serum creatinine to eGFR, Letter reply. Diabetic Medicine; 24: 572–573
Heald A, Patel J, Anderson S, Vyas A, Rudenski A, Hughes E, Panja N, Ullah A, Prabhakaran D, Reddy
S, Gibson JM et al (2007) Migration is associated with lower total, but not free testosterone levels in
South Asian men. Clinical Endocrinology 67:651-655
JP New, RJ Middleton, B Klebe, C Farmer, S de Lusignan, P Stevens, DJ O’Donoghue (2007) Assessing
the prevalence, monitoring and management of chronic kidney disease in patients with diabetes
compared to those without diabetes in general practice. Diabetic Medicine; 24: 364-369
Heald A, Anderson S, Patel J, Rudenski A, Vyas A, Yates A, Hughes E, Prabharakan D, Reddy S,
Durrington P, Gibson JM et al (2007) Change in pancreatic B‐cell function (HOMA‐B) varies in
different populations with similar genetic backgrounds but different environments. Diabetic
Medicine 24:145-153
Betteridge DJ, Gibson JM, Sager PT (2007) Comparison of Effectiveness of Rosuvastatin Versus
Atorvastatin on the Achievement of Combined C-Reactive Protein (< 2 mg/L) and Low-Density
Lipoprotein Cholesterol (< 70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the
ANDROMEDA Study). The American journal of cardiology 100:1245-1248
Betteridge D, Gibson JM (2007) Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in
the dyslipidaemia of diabetes. Diabetic Medicine 24:541-549
Klebe B, Farmer C, Cooley R, de Lusignan S, Middleton R, O'Donoghue D, New J, Stevens P. (2007)
Kidney disease management in UK primary care: guidelines, incentives and Information Technology.
Family Practice.
Klebe B, Irving J, Stevens PE, O'Donoghue DJ, Lusignan SD, Cooley R, Hobbs H, Lamb EJ, John I,
Middleton R, New J, Farmer CK (2007) The cost of implementing UK guidelines for the management
of chronic kidney disease. Nephrol Dial Transplant; 22:
Salonen JT, Uimari P, Aalto J-M, Pirskanen M, Kaikkonen J, Todorova B, Hyppönen J, Korhonen V-P,
Asikainen J, Devine C, Gibson JM et al (2007) Type 2 diabetes whole-genome association study in
four populations: the DiaGen consortium. The American Journal of Human Genetics 81:338-345
Heald A, Patel J, Anderson S, Vyas A, Rudenski A, Hughes E, Panja N, Ullah A, Prabhakaran D, Reddy
S, Gibson JM et al (2007) Migration is associated with lower total, but not free testosterone levels in
South Asian men. Clinical Endocrinology 67:651-655
Heald A, Anderson S, Patel J, Rudenski A, Vyas A, Yates A, Hughes E, Prabharakan D, Reddy S,
Durrington P, Gibson JM et al (2007) Change in pancreatic B‐cell function (HOMA‐B) varies in
different populations with similar genetic backgrounds but different environments. Diabetic
Medicine 24:145-153
Betteridge DJ, Gibson JM, Sager PT (2007) Comparison of Effectiveness of Rosuvastatin Versus
Atorvastatin on the Achievement of Combined C-Reactive Protein (< 2 mg/L) and Low-Density
Lipoprotein Cholesterol (< 70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the
ANDROMEDA Study). The American journal of cardiology 100:1245-1248
PE Stevens, DJ O’Donoghue, S de Lusignan, J Van Vlymen, B Klebe, RJ Middleton, N Hague, J New,
CKT Farmer (2007) Kidney International; 72: 92-99 Management of Chronic Kidney Disease in the
United Kingdom: Results from the NEOERICA Project
Betteridge D, Gibson JM (2007) Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in
the dyslipidaemia of diabetes. Diabetic Medicine 24:541-549
Stewart MF, Croft J, Reed P, New JP (2007) Acute intermittent porphyria and phaeochromocytoma:
shared features Journal of Clinical Pathology J Clin Path 2007; 60:9 35-960
Ainsworth J, Harper R, Bridges L, Whelan P, Vance W, Buchan I, Lewis S. (2007). e-Infrastructure for
Cohort Studies and Trials. Presented at Public Health Informatics 2007. Seattle. eScholarID:71429
2006
PT Donnan, L Donnelly, JP New, AD Morris (2006) Derivation and Validation of a Prediction Score for
Coronary Heart Disease (CHD) in a UK type 2 diabetes population. Diabetes Care; 29:1231-1236.
Ainsworth J, Harper R, Juma I, Buchan IE. (2006). Design and implementation of security in a data
collection system for epidemiology. eScholarID:2d2014
JP New (2006) Improving the quality of care for patients with chronic kidney disease and diabetes.
Practical Diabetes 2006; 23; 8-9
Jarvis P, Patterson LE, Verma A, Harrison RA, Buchan IE. (2006). Measuring children and monitoring
obesity: Surveys of Englis Primary Care Trusts 2004-2006. Journal of Public Health, 28(4), 330-336.
eScholarID:1d14499Reviewed Publications
Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, Kalra PA, O'Donoghue DJ,
New JP (2006) The unrecognized prevalence of chronic kidney disease in diabetes. Nephrology
Dialysis Transplantation 21:88-92
Mason JM, Young RJ, New JP, Gibson JM, Long AF, Gambling T, Friede T (2006) Economic analysis of
a telemedicine intervention to improve glycemic control in patients with diabetes mellitus. Disease
Management & Health Outcomes 14:377-385
Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK,
White A, Gibson JM (2006) Low insulin-like growth factor-II levels predict weight gain in normal
weight subjects with type 2 diabetes. The American journal of medicine 119:167. e169-167. e115
Heald A, Stephens R, Gibson JM (2006) The insulin‐like growth factor system and diabetes—an
overview. Diabetic Medicine 23:19-24
Heald A, Kaushal K, Siddals K, Rudenski A, Anderson S, Gibson JM (2006) Insulin-like growth factor
binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Experimental and Clinical
Endocrinology & Diabetes 114:371-376
JP New, DJ O’Donoghue, RJ Middleton, A Rudenski, I Dasgupta, R W Bilous, SM Marshall (2006) Time
to move from serum creatinine to eGFR. Diabetic Medicine; 23: 1047-1048
Castleden H, Shields B, Bingley P, Williams A, Sampson M, Walker M, Gibson JM, McCarthy M,
Hitman G, Levy J (2006) GAD antibodies in probands and their relatives in a cohort clinically selected
for type 2 diabetes. Diabetic Medicine 23:834-838
A Mukherjee, P Twomey, D O’Donoghue, A Rudenski, JP New (2006) Estimated GFR (eGFR) testing in
the UK; the need for a consensus statement British Medical Journal 2006; 332: 794